EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.19.3 | 2-oxoimidazolidinyl-4-carbonyl-Gly-Ile + H2O |
- |
Bos taurus |
? |
- |
? |
3.4.19.3 | 4(R)-N-(2-nitroxyethyl)-2-oxothiazolidine-4-carboxamide + H2O |
- |
Mus musculus |
L-2-oxothiazolidine-4-carboxylic acid + ? |
- |
? |
3.4.19.3 | 4(R)-N-(2-nitroxyethyl)-2-oxothiazolidine-4-carboxamide + H2O |
- |
Homo sapiens |
L-2-oxothiazolidine-4-carboxylic acid + ? |
- |
? |
3.4.19.3 | 4(R)-N-(2-nitroxyethyl)-2-oxothiazolidine-4-carboxamide + H2O |
- |
Rattus norvegicus |
L-2-oxothiazolidine-4-carboxylic acid + ? |
- |
? |
3.4.19.3 | 5-pyrrolidone-2-carboxyl-His-Gly + H2O |
slight activity |
Cavia porcellus |
? |
- |
? |
3.4.19.3 | 5-pyrrolidone-2-carboxyl-His-Trp + H2O |
- |
Cavia porcellus |
? |
- |
? |
3.4.19.3 | ACE inhibitor + H2O |
contains the N-terminal dipeptide pyroglutamyl-Trp- |
Homo sapiens |
pyroglutamate + ? |
- |
? |
3.4.19.3 | acid-thyroliberin + H2O |
- |
Cavia porcellus |
pyroglutamate + His-Pro |
- |
? |
3.4.19.3 | acid-thyroliberin + H2O |
i.e. pyroglutamyl-His-Pro |
Cavia porcellus |
pyroglutamate + His-Pro |
- |
? |
3.4.19.3 | bombesin + H2O |
- |
Bos taurus |
pyroglutamate + Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
- |
? |